Relmada Therapeutics Announces Publication of REL1017 Phase 1 Studies Results
Research Findings Accepted for Publication in Journal of Clinical Psychopharmacology
News
IView Therapeutics was awarded SBIR Innovative Year 2 Grant by NIH’s National Institute of Allergy and Infectious Diseases (NIAID)
Gina DiGuglielmo Joins Relmada as Vice President and Head of Clinical Operations
Ms. DiGuglielmo consolidates and expands her role from advisor to a full-time position to lead Relmada’s clinical operations
VenatoRx Pharmaceuticals Awarded NIAID R01 Grant to Uncover Determinants of Gram-Negative Permeability
Leveraging a Unique Small Molecule Library, VenatoRx seeks to open challenging bottlenecks for antibacterial drug discovery and successfully introduce new antibacterial agents into the clinic
Children’s of Alabama Selects Bainbridge Health to Support its Continued Commitment to Medication Safety and Stewardship
Bainbridge Health is partnering with Children’s of Alabama, ranked among the best pediatric medical centers in the nation by U.S. News and World report, to further bolster its efforts to improve medication safety and stewardship.
ENB Therapeutics Announces Clinical Trial Collaboration with Merck to Evaluate ENB-003 in combination with KEYTRUDA(R) (pembrolizumab) for Advanced Solid Tumors